Back to today’s briefing

Story perspectives

Revolutionary Pill Mimics Gastric Bypass for Weight Loss

4/10/2025

47 9

Summary

Story summary

Syntis Bio, a Boston-based company, is making waves with a groundbreaking daily pill designed to replicate the effects of gastric bypass surgery for weight loss. Unveiling promising early safety data at the European Congress on Obesity, this innovative drug alters nutrient absorption in the small intestine, providing a potentially more appealing option than costly GLP-1 injections that often lead to user dropouts due to side effects.

1 of 1

Story summary

Syntis Bio, a Boston-based company, is making waves with a groundbreaking daily pill designed to replicate the effects of gastric bypass surgery for weight loss. Unveiling promising early safety data at the European Congress on Obesity, this innovative drug alters nutrient absorption in the small intestine, providing a potentially more appealing option than costly GLP-1 injections that often lead to user dropouts due to side effects.